Mineralys Therapeutics, Inc.'s market cap is currently $474.93M. The company's EPS TTM is $-3.643; its P/E ratio is ―; Mineralys Therapeutics, Inc. is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-1.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -192.40M	$ -84.66M	$ -31.48M	$ -18.73M	$ -2.94M
EBITDA	$ -192.40M	$ -84.66M	$ -31.48M	$ 0.00	$ 0.00
Net Income	$ -177.81M	$ -71.90M	$ -29.80M	$ -19.41M	$ -3.43M
Balance Sheet
Cash & Short-Term Investments	$ 198.19M	$ 236.57M	$ 110.11M	$ 10.61M	$ 1.41M
Total Assets	$ 205.90M	$ 251.64M	$ 114.44M	$ 11.13M	$ 1.49M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 4.50M
Net Debt	$ -114.09M	$ -49.30M	$ -87.70M	$ -10.61M	$ 3.09M
Total Liabilities	$ 14.65M	$ 10.48M	$ 166.71M	$ 34.05M	$ 5.08M
Stockholders' Equity	$ 191.26M	$ 241.15M	$ -52.27M	$ -22.93M	$ -3.60M
Cash Flow
Free Cash Flow	$ -166.41M	$ -81.17M	$ -29.22M	$ -14.56M	$ -2.46M
Operating Cash Flow	$ -166.31M	$ -81.17M	$ -29.22M	$ -14.56M	$ -2.46M
Investing Cash Flow	$ 114.96M	$ -160.47M	$ -21.76M	$ 0.00	$ 0.00
Financing Cash Flow	$ 116.14M	$ 203.25M	$ 128.02M	$ 23.81M	$ 3.83M

Currency in USD

Mineralys Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Mineralys Therapeutics, Inc. Debt to Assets

Balance Sheet >

Mineralys Therapeutics, Inc. Cash Flow

Cash Flow >

Mineralys Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing